Repligen | RGEN - Ebit




Repligen reported $23.1M in EBIT for its fiscal quarter ending in September of 2024.

Ebit Change Date
Agilent USD 464M 32M Oct/2024
Align Technology USD 230.43M 14.53M Dec/2024
Bio Techne USD 88.71M 5.48M Dec/2024
BioMarin Pharmaceutical USD 113.89M 21.82M Sep/2024
Bristol-Myers Squibb USD 4.21B 2.03B Dec/2024
Bruker USD 177.5M 48.4M Dec/2024
Charles River Laboratories USD 199.53M 915K Dec/2024
Danaher USD 1.93B 868M Dec/2024
Dentsply International USD 136M 3M Sep/2024
Exact Sciences USD -40755000 179.12M Dec/2024
General Electric USD 1.99B 156M Dec/2024
Henry Schein USD 213M 49M Sep/2024
Illumina USD 218M 26M Dec/2024
IQVIA Holdings USD 845M 57M Dec/2024
Mettler Toledo International USD 351.92M 55.35M Dec/2024
Myriad Genetics USD 9.5M 45.9M Sep/2024
Patterson Companies USD 60.65M 25.39M Oct/2024
Pfizer USD 4.62B 2.42B Dec/2024
Repligen USD 23.1M 12.94M Sep/2024
Revvity USD 221.3M 27.8M Dec/2024
Standard Biotools USD -31718000 18.8M Sep/2024
Thermo Fisher Scientific USD 2.72B 358M Dec/2024
Waters USD 309.39M 81.43M Dec/2024
West Pharmaceutical Services USD 162.8M 2.4M Dec/2024